Branding has always been something of an afterthought in life sciences, where the focus is on the product rather than the company or the people. That may be part of the reason for the public’s famous distrust of the industry. But as Vanguard Principal Ken Banta and Straightline CEO Michael Watras discuss in this video, the pandemic has created an opening for a new approach.